These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3085701)

  • 1. Molecular evidence for the clonal origin of blast crisis in chronic myeloid leukaemia.
    Zalcberg JR; Friedlander ML; Minden MD
    Br J Cancer; 1986 Apr; 53(4):459-64. PubMed ID: 3085701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular genetics of the pathogenesis and classification of chronic myelocytic leukemia].
    Bartram CR
    Onkologie; 1987 Jun; 10(3):127-32. PubMed ID: 3306531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural organization of the bcr gene and its role in the Ph' translocation.
    Heisterkamp N; Stam K; Groffen J; de Klein A; Grosveld G
    Nature; 1985 Jun 27-Jul 3; 315(6022):758-61. PubMed ID: 2989703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonal rearrangement and expression of the T cell receptor beta gene and involvement of the breakpoint cluster region in blast crisis of CGL.
    Chan LC; Furley AJ; Ford AM; Yardumian DA; Greaves MF
    Blood; 1986 Feb; 67(2):533-6. PubMed ID: 3002526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myeloid leukaemia lymphoid blast crisis. Relevance of molecular analysis at the bcr and immunoglobulin heavy chain gene level in monitoring response to therapy and residual disease.
    Lo Coco F; Diverio D; Frontani M; Wang YZ; Montefusco E; De Fabritiis P; Arcese W; De Rossi G; Mandelli F
    Eur J Haematol; 1991 Mar; 46(3):172-6. PubMed ID: 1901272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CML patients in blast crisis have breakpoints localized to a specific region of the BCR.
    Schaefer-Rego K; Dudek H; Popenoe D; Arlin Z; Mears JG; Bank A; Leibowitz D
    Blood; 1987 Aug; 70(2):448-55. PubMed ID: 3038213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-lymphoid blast crisis of CML with rearrangement of immunoglobulin and T-cell receptor delta genes.
    Bashey A; Vulliamy T; Cai BS; Schwarer AP; Goldman JM
    Eur J Haematol; 1991 Jul; 47(1):36-41. PubMed ID: 1907927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell population analysis of a heterogeneous blast cell crisis of chronic myelogenous leukemia.
    Pedraza MA; Mason D; Doslu FA; Marsh RA; Boblett JP
    Diagn Immunol; 1984; 2(1):19-24. PubMed ID: 6594209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of P210bcr-abl tyrosine protein kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients.
    Maxwell SA; Kurzrock R; Parsons SJ; Talpaz M; Gallick GE; Kloetzer WS; Arlinghaus RB; Kouttab NM; Keating MJ; Gutterman JU
    Cancer Res; 1987 Mar; 47(6):1731-9. PubMed ID: 2434223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic diversity correlates with clinical variation in Ph'-negative chronic myeloid leukaemia.
    Morris CM; Reeve AE; Fitzgerald PH; Hollings PE; Beard ME; Heaton DC
    Nature; 1986 Mar 20-26; 320(6059):281-3. PubMed ID: 3007992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The morphological, immunophenotypical and cytogenetic characteristics study of blast crisis in chronic myeloid leukemia].
    Tang X; Wu D; Xue Y; Zhu M; Lu D; Ruan C
    Zhonghua Nei Ke Za Zhi; 2002 Oct; 41(10):685-7. PubMed ID: 12485536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
    González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
    Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of chronic myelocytic leukemia despite deletion of rearranged bcr/c-abl sequences in blast crisis.
    Bartram CR; Janssen JW; Becher R; de Klein A; Grosveld G
    J Exp Med; 1986 Nov; 164(5):1389-96. PubMed ID: 3464689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis.
    Collins SJ
    J Clin Invest; 1986 Nov; 78(5):1392-6. PubMed ID: 3021820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
    Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
    Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
    N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
    Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant Philadelphia translocation in an immunologically and clinically typical case of chronic myeloid leukaemia.
    Donti E; Tabilio A; Donti GV; Carotti A; Falsetti F; Rosetti A
    Leuk Res; 1985; 9(9):1149-53. PubMed ID: 3865032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoid blast crisis in a patient with Philadelphia-chromosome-negative chronic myelocytic leukemia.
    Takahira H; Shibata K; Hirata J; Umemura T; Nishimura J; Nawata H
    Acta Haematol; 1989; 81(3):155-9. PubMed ID: 2496564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basophils (Bsp-1+) derive from the leukemic clone in human myeloid leukemias involving the chromosome breakpoint 9q34.
    Bodger MP; Morris CM; Kennedy MA; Bowen JA; Hilton JM; Fitzgerald PH
    Blood; 1989 Feb; 73(3):777-81. PubMed ID: 2644988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.